ANIP ANI PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2024 - Private Offering ANI Pharmaceuticals announced the pricing of its private offering of $275 million aggregate principal amount of 2.25% Convertible Senior Notes due 2029 to qualified institutional buyers.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC